Skip to main content
Menu
Navne

MD, PhD Morten Frost receives prestigious grant from the Novo Nordisk Foundation

10 million DKK to support studies on the role of the hormone GLP-1 and the potential of GLP-1 like drugs to be used as a treatment for skeletal fragility in patients with osteoporosis or diabetes

MD, PhD Morten Frost has received the prestigious Excellence Emerging Investigator Grant – Endocrinology & Metabolism 2019 from the Novo Nordisk Foundation for the project GLucagon-like peptide One & BonE (GLOBE): Studies on the role of GLP-1 as a nutrient sensing mechanism regulating bone metabolism 

Further information on SDCO's webpage

Editing was completed: 12.04.2019